The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 987.40
Bid: 986.00
Ask: 986.40
Change: 13.00 (1.33%)
Spread: 0.40 (0.041%)
Open: 978.40
High: 988.00
Low: 977.40
Prev. Close: 974.40
PSON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pearson Announces Sale - Local Courseware Business

12 Aug 2022 11:21

RNS Number : 8831V
Pearson PLC
12 August 2022
 

Pearson Announces Sale of Local Courseware Business in South Africa

 

LONDON, 12 August 2022: In March 2021, Pearson, the world's leading learning company, announced a strategic review of its International Courseware local publishing businesses. This transaction forms part of that process and follows the disposal of our K12 business in Brazil and our K12 courseware French Canadian business, as well as agreements to sell our K12 businesses in Italy, Germany, and Hong Kong.

 

Today, Pearson announces that it has agreed to sell its 75% share of the K12, TVET and local Higher Education Courseware business in South Africa to Novus Holdings Limited ("Novus Holdings"), with its headquarters in Cape Town, South Africa, and listed on the Johannesburg Stock Exchange (JSE). Novus Holdings is a specialised printing and packaging manufacturing group which services customers across sub-Saharan Africa through an extensive and diverse range of products and solutions. The headline consideration of this transaction is £53m, which will be received on completion, subject to typical working capital and net debt changes and adjusted to reflect our 75% share. The transaction remains subject to customary closing conditions, including regulatory and Novus Holdings shareholder approval.

 

The South African K12, TVET and local Higher Education Courseware business had gross assets of £15m and net assets of £5m as at 30 June 2022. The businesses generated £44.4m of revenue and £10.3m of adjusted operating profit in 2021.

 

The sale of this business concludes the review of our international courseware local publishing businesses, where we have achieved a blended multiple of 14.1x EV/EBITDA 2021.

 

As previously stated, the proceeds of this transaction were anticipated in the decision to commence Pearson's £350m share buyback programme, which is progressing well, with over £170m in shares repurchased since launch.

 

In 2021, the businesses which we put under strategic review ("strategic review businesses") contributed revenue of £252m, and £22m in adjusted operating profit. The impact of disposals of strategic review businesses on Pearson's 2022 adjusted operating profit will depend upon the timing of transaction completions, but is expected to be £15m-£20m, reflecting the second half weighting of their financial contributions. Operating cash flow for these businesses is weighted to Q4 and the timing of completion is therefore also likely to impact operating cash conversion in 2022, with an offset in the transaction working capital adjustment, recorded within cash from investing activities. As we announced recently, we have decided to retain our Australian and English-speaking Canadian K12 Courseware businesses to deliver increased shareholder value as part of the Group. 

 

BNP Paribas has acted as exclusive financial adviser to Pearson plc regarding the review of its International Courseware local publishing businesses.

 

 

---ENDS---

 

 

Contacts 

 

Investor Relations

Jo Russell

James Caddy

 +44 (0) 7785 451 266

 +44 (0) 7825 948 218

Media

Tom Steiner

Gemma Terry

 +44 (0) 7787 415 891

 +44 (0) 7841 363 216

Teneo

Charles Armitstead

 +44 (0) 7703 330 269

 

Forward looking statements: 

Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations, and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated cost savings and synergies and the execution of Pearson's strategy, are forward looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future. There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national, and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly filed documents and you are advised to read, in particular, the risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (www.pearsonplc.com/investors). 

 

Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUUARRUKUWAAR
Date   Source Headline
17th May 20234:50 pmRNSDirector/PDMR Shareholding
16th May 20234:16 pmRNSDirector/PDMR Shareholding
10th May 20234:30 pmRNSDirector/PDMR Shareholding
10th May 202310:49 amRNSDirectorate Change
9th May 20234:15 pmRNSHolding(s) in Company
9th May 20239:00 amRNSPearson: Generative AI Strategy Update
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
3rd May 20234:13 pmRNSHolding(s) in Company
2nd May 20233:57 pmRNSTotal Voting Rights
28th Apr 20231:11 pmRNSResult of AGM
28th Apr 20237:00 amRNSPearson 2023 Q1 Trading Update
20th Apr 20234:19 pmRNSHolding(s) in Company
11th Apr 20239:17 amRNSHolding(s) in Company
4th Apr 20234:30 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
31st Mar 20233:44 pmRNSForm 20-F for the year ended 31 December 2022
31st Mar 20232:29 pmRNSHolding(s) in Company
28th Mar 202311:17 amRNSDirector Declaration
27th Mar 20234:05 pmRNSHolding(s) in Company
24th Mar 202312:30 pmRNSNotice of AGM
23rd Mar 20237:00 amRNSPearson Completes Acquisition of PDRI
21st Mar 20237:00 amRNSPearson to sell POLS
16th Mar 20233:09 pmRNSAnnual Financial Report
16th Mar 202311:28 amRNSDirector Declaration
7th Mar 20234:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPearson 2022 Preliminary Results
2nd Mar 20233:37 pmRNSCommittee Change
1st Mar 202310:10 amRNSTotal Voting Rights
8th Feb 20232:37 pmRNSHolding(s) in Company
3rd Feb 20234:23 pmRNSDirector/PDMR Shareholding
1st Feb 202311:10 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSPearson 2022 Trading Update
4th Jan 20233:04 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSTotal Voting Rights
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
19th Dec 202212:00 pmRNSPearson to Acquire PDRI
16th Dec 20224:38 pmRNSCompletion of Redemption - Guaranteed Notes
14th Dec 20222:52 pmRNSSecond/Further Notice - Guaranteed Notes
7th Dec 20226:06 pmRNSTransaction in Own Shares
6th Dec 20226:02 pmRNSTransaction in Own Shares
5th Dec 20225:55 pmRNSTransaction in Own Shares
2nd Dec 20226:11 pmRNSTransaction in Own Shares
1st Dec 20225:44 pmRNSTransaction in Own Shares
1st Dec 20224:11 pmRNSBlock listing Interim Review
1st Dec 20224:05 pmRNSTotal Voting Rights
30th Nov 20225:56 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.